SBC Medical Group Holdings Incorporated (SBC) Stock Forecast
Data as of May 2, 2026Industrials · Current price $3.27 (-0.91%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Aug 14, 2024 | John Todaro | Needham | $15.00 | +358.7% |
Top Analysts Covering SBC
SBC vs Sector & Market
| Metric | SBC | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | — | 2.41 | 2.41 |
| Analyst Count | — | 8 | 18 |
| Target Upside | +175.2% | +84.6% | +14.9% |
| P/E Ratio | 6.65 | 28.18 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $177M | $179M | $181M | 4 |
| 2027-03-31 | $44M | $45M | $45M | 1 |
| 2027-06-30 | $48M | $49M | $49M | 2 |
| 2027-09-30 | $47M | $48M | $49M | 2 |
| 2027-12-31 | $50M | $51M | $52M | 1 |
| 2028-03-31 | $44M | $45M | $46M | 1 |
| 2028-06-30 | $49M | $50M | $50M | 1 |
| 2028-09-30 | $48M | $49M | $49M | 1 |
| 2028-12-31 | $54M | $55M | $56M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.44 | $0.45 | $0.46 | 3 |
| 2027-03-31 | $0.11 | $0.11 | $0.12 | 1 |
| 2027-06-30 | $0.12 | $0.12 | $0.13 | 1 |
| 2027-09-30 | $0.12 | $0.12 | $0.12 | 1 |
| 2027-12-31 | $0.13 | $0.13 | $0.13 | 1 |
| 2028-03-31 | $0.11 | $0.11 | $0.12 | 1 |
| 2028-06-30 | $0.12 | $0.13 | $0.13 | 1 |
| 2028-09-30 | $0.12 | $0.12 | $0.13 | 1 |
| 2028-12-31 | $0.14 | $0.14 | $0.14 | 1 |
Frequently Asked Questions
What is the analyst consensus for SBC?
The consensus among 0 analysts covering SBC Medical Group Holdings Incorporated (SBC) is — with an average price target of $9.00.
What is the highest price target for SBC?
The highest price target for SBC is $15.00, set by John Todaro at Needham on 2024-08-14.
What is the lowest price target for SBC?
The lowest price target for SBC is $15.00, set by John Todaro at Needham on 2024-08-14.
How many analysts cover SBC?
0 analysts have issued ratings for SBC Medical Group Holdings Incorporated in the past 12 months.
Is SBC a buy or sell right now?
Based on 0 analyst ratings, SBC has a consensus rating of — with a +175.2% upside to the consensus target of $9.00.
What are the earnings estimates for SBC?
Analysts estimate SBC will report EPS of $0.45 for the period ending 2026-12-31, with revenue estimated at $179M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.